When discussing cardiac surgery, predicting surgical risk is essential for patients, surgeons, and medical teams. Tools such as EuroSCORE, the STS Score, and the Ambler Score enable the accurate estimation of postoperative mortality and morbidity risks.

EuroSCORE (European System for Cardiac Operative Risk Evaluation), developed by the European Association of Cardio-Thoracic Surgery, is highly regarded. It is used to predict 30-day postoperative mortality following cardiac surgery by analyzing various clinical factors related to the patient as well as the characteristics of the procedure.

These calculators are not limited to statistical analyses.

They are key clinical tools that help provide patients with more information and guide surgical decisions to ensure optimal care.

Understanding Risk Calculators in Cardiac Surgery

The Importance of Risk Calculators

Risk calculators in cardiac surgery play an essential role in medical decision-making. These tools enable the estimation of operative mortality and morbidity, thereby helping surgeons and patients assess the risk-benefit ratio of surgical interventions. They reduce the degree of subjectivity in surgical risk assessment and provide an objective basis for discussing treatment options and potential risks with patients. Furthermore, these calculators are essential for improving the quality of care in cardiac surgery and ensuring greater transparency in outcomes. By providing standardized data, they facilitate performance comparisons between different surgical centers and allow for the clear identification of areas requiring improvement. This can range from optimizing surgical practices to adjusting postoperative follow-up protocols. Furthermore, these tools help optimize available resources and allow for more effective planning of postoperative care by anticipating potential complications. Overview of the different scores: Currently, several risk calculators are used in cardiac surgery, each with its own characteristics and advantages. The choice of a score often depends on the nature of the planned surgical procedure as well as the patient’s specific profile. For example, the EuroSCORE, developed by the European Association of Cardio-Thoracic Surgery, is one of the most widely used risk stratification systems. It is distinguished by its ease of use and its ability to reliably estimate 30-day mortality after cardiac surgery. There are two main versions of this score: the additive version and the logistic version, while the more recent EuroSCORE II offers increased accuracy thanks to methodological adjustments. On the other hand, the STS (Society of Thoracic Surgeons) score, based on a comprehensive American database, takes into account a much larger number of variables compared to EuroSCORE. It is particularly well-suited for various complex surgical procedures, such as coronary artery bypass grafting and valve replacement. Furthermore, it allows for the estimation not only of operative mortality but also of the morbidity associated with these interventions. For patients with valvular heart disease, the Ambler score is particularly relevant. Developed using data from the Society of Cardiothoracic Surgeons of Great Britain and Ireland, it provides an accurate estimate of in-hospital mortality in patients undergoing valve surgery. Although each of these scores employs specific approaches, they all share a common goal: to offer a robust and reliable assessment of operative risk. This allows for more informed medical decisions and better organization of care for patients requiring cardiac intervention.

The EuroSCORE

History and Evolution of the EuroSCORE

The EuroSCORE, or European System for Cardiac Operative Risk Evaluation, was initiated by Samer Nashef and François Roques in the 1990s. This ambitious project drew on data collected from approximately 20,000 patients across 128 hospitals in eight European countries. This data collection focused on 97 risk factors, enabling the creation of a precise risk profile for each patient and the estimation of postoperative mortality. Published in 1999, the first EuroSCORE model was immediately adopted worldwide, becoming the standard for risk prediction in cardiac surgery. However, advances in surgical techniques and postoperative care have highlighted the need for an update. In response, EuroSCORE II was announced in 2011 and published in 2012, offering significantly improved calibration and accuracy.

How the EuroSCORE is calculated

The EuroSCORE calculation is based on 17 parameters related to the patient, cardiac conditions, and the nature of the planned procedure. These parameters include:

• Patient-related factors: age, sex, chronic lung disease, etc.
• Cardiac factors: unstable angina, reduced ventricular ejection fraction, etc.
• Operational factors: urgency of the procedure, type of surgery planned, etc.

The information collected in this way is then incorporated into a logistic regression model to predict postoperative mortality. The initial model was based on an additive approach, whereas more recent versions, including the logistic model and EuroSCORE II, allow for a more refined assessment by incorporating precise numerical values for certain variables, such as pulmonary artery pressure and ejection fraction.

Limitations and Accuracy of EuroSCORE

Although widely used and having contributed to improved outcomes in cardiac surgery, EuroSCORE has limitations. One challenge is inter-observer reliability, as the coding of risk factors can vary from one clinician to another. Any variation in data interpretation can therefore introduce bias into the final calculation.

Furthermore, the initial model sometimes tended to overestimate the risk of mortality, particularly for certain procedures such as valve surgeries. Fortunately, EuroSCORE II corrected these overestimates by improving both the calibration and the predictive power of the model.

These improvements underscore the ongoing importance of refining risk assessment models to reflect ongoing advances in cardiac surgery and provide patients with the most rigorous and accurate surgical risk estimate possible.

The STS Score

Development and Application of the STS Score

The STS Score (Society of Thoracic Surgeons) is derived directly from the extensive database of the Society of Thoracic Surgeons, based in the United States. This score was specifically designed to provide an accurate estimate of postoperative mortality and morbidity risks in cardiac surgery. It is widely recognized and used in thoracic surgery centers to assess the surgical risk of patients undergoing various cardiac procedures, including coronary artery bypass grafting, valve replacement, and other complex surgical procedures. Furthermore, the STS score is distinguished by its high degree of flexibility. It features models tailored to each type of cardiac surgery, allowing for an even more precise risk assessment tailored to the specific procedure and the patient’s needs. Thus, it promotes a personalized and refined surgical approach.

Calculation and Components of the STS Score

The calculation of the STS Score is based on a wide range of variables, far more numerous than those considered by the EuroSCORE. These variables include, in particular, age, sex, medical history (such as coronary artery disease or heart failure), and factors such as ventricular function and pulmonary artery pressure. When combined in advanced statistical models, these data enable a detailed and reliable estimation of the probabilities of postoperative complications or death.

Unlike the EuroSCORE, which can be calculated using either an additive or logistic approach, the STS Score requires the use of specific software or online calculators to be generated accurately. This mathematically rigorous approach guarantees remarkable accuracy, but it may prove slightly less practical in situations requiring rapid bedside assessment. Advantages and disadvantages of the STS Score compared to the EuroSCORE: The main advantage of the STS Score lies in its ability to assess not only operative mortality but also associated morbidity. This broader view of surgical risks helps surgeons make more informed and appropriate decisions. Furthermore, it is often considered more accurate than the EuroSCORE, particularly for patients in intermediate or high-risk categories. This is due to the inclusion of a greater number of variables and significantly more sophisticated statistical models. Nevertheless, some limitations remain. The complexity of its calculation can be a hindrance, particularly in emergency situations where speed is essential. Furthermore, it may underestimate the risk for some patients with extreme risk factors or those requiring atypical interventions. In conclusion, the STS Score stands out as a particularly precise and flexible tool. However, it requires a certain level of technical expertise and may have limitations in specific situations. Its use will depend on the clinical context and the specific requirements of the patient and the healthcare team.

The Ambler Score

Origins and Uses of the Ambler Score

The Ambler Score was designed specifically for patients with valvular heart disease, based on a database developed by the Society of Cardiothoracic Surgeons of Great Britain and Ireland. This score is intended to estimate in-hospital mortality in patients requiring heart valve surgery. It appears to be particularly useful in the context of procedures involving valves such as the aortic or mitral valve, whether or not these are performed in conjunction with coronary artery bypass grafting.

The main strength of the Ambler Score lies in its ability to provide an accurate and targeted prediction of mortality risks in a specific population: patients undergoing valvular surgery. This enables medical teams to plan the care pathway more effectively and to clearly inform patients about the risks and benefits associated with their surgery.

Methodology for Calculating the Ambler Score

The Ambler Score is calculated using a national database that analyzed more than 32,000 patients during its development and validation phase. This score incorporates a combination of clinical factors specific to patients requiring heart valve surgery. Thanks to this methodology, it is particularly effective at accurately predicting in-hospital mortality in this specific context.

Unlike other assessment tools such as the EuroSCORE or the STS Score, which are applicable to a wide variety of cardiac surgeries, the Ambler Score stands out for its specialized focus. This specificity makes it a robust and useful tool for surgeons and medical teams seeking to predict postoperative outcomes in the context of valvular surgery.

Comparison of the Ambler Score with other scores

The Ambler Score stands out as a tool designed for specific indications, which sets it apart from other tools such as the EuroSCORE or the STS Score. The latter are general-purpose scores that cover a wide range of cardiac surgery procedures. In contrast, the Ambler Score offers greater accuracy when used in the context of valvular surgery, due to its specialized design.

However, studies have shown that this score can sometimes overestimate risks, particularly in the highest-risk quartiles. Despite this limitation, the Ambler Score retains good discriminatory power, effectively distinguishing between low-risk and high-risk patients. While the EuroSCORE II and the STS score are sometimes better calibrated, this does not diminish the relevance of the Ambler Score for specific valvular heart disease. It therefore remains a valuable tool for practitioners specializing in this type of procedure. Comparison and selection of the appropriate score: Factors influencing score selection: The choice of the appropriate risk score in cardiac surgery relies on a thorough analysis of several essential criteria. First, the nature and complexity of the surgical procedure are central to this decision. For example, the STS score is frequently preferred for complex or combined procedures, such as coronary artery bypass grafting combined with valve surgery, because it offers remarkable accuracy in the simultaneous assessment of operative mortality and morbidity risks. Furthermore, the patient’s individual characteristics play a key role. The Ambler score, designed specifically for patients with valvular heart disease, is particularly relevant due to its ability to provide a precise estimate of the risk of in-hospital mortality. The accessibility and ease of use of scores cannot be overlooked. For example, the EuroSCORE, in its additive version, is often chosen for its simplicity and speed of calculation, making it ideal in emergency situations requiring rapid decision-making. Practical application of scores in clinical decision-making: In a clinical setting, risk scores are integrated into the decision-making process to accurately assess the benefit-risk ratio of surgical interventions. They allow surgeons and medical teams to provide patients with informed information about the potential risks and benefits of surgery. For example, a patient with a high-risk score using the EuroSCORE or STS score should be engaged in a thorough discussion about possible treatment alternatives or preoperative preparation measures to minimize risks. Furthermore, these scores help optimize the management of medical resources. Thus, a patient identified as high-risk may require intensive monitoring in postoperative care, including specific cardiac support measures. Impact of Scores on Cardiac Surgery Outcomes: Integrating risk scores into surgical practices positively influences outcomes in cardiac surgery. By reducing subjectivity in risk assessment, these tools allow for more precise patient stratification and better-informed decisions. This process can significantly reduce postoperative mortality and morbidity, particularly by reserving appropriate resources for higher-risk patients. Furthermore, it facilitates the comparison of outcomes between different cardiac surgery centers, which contributes to the identification of best practices and the improvement of standards of care.

Finally, these scores play a key role in evaluating innovative techniques and surgical protocols, thereby paving the way for continuous improvement in cardiac surgery outcomes.

In short, their integration into clinical practice promotes a more systematic and precise approach to managing the risks associated with cardiac surgery.

Recent and future developments in risk calculators

Technological Innovations and New Computational Models

Risk calculators in cardiac surgery are constantly evolving, thanks to technological advances and progress in data analysis. A major innovation recently introduced is the integration of artificial intelligence (AI) into prediction models. For example, the Oxford Risk Factors And Noninvasive Imaging (ORFAN) cohort study led to the development of an AI-enhanced cardiac risk prediction algorithm. This model combines the perivascular fat attenuation index (FFI) with coronary plaque measurements and clinical risk factors. This model has been shown to be positively associated with cardiac mortality and coronary events, particularly in patients without significant coronary stenosis. Furthermore, traditional tools such as EuroSCORE and the STS score continue to be improved. EuroSCORE II, for example, has replaced previous models and now relies on 18 clinical characteristics for a more refined and personalized assessment of surgical risks. At the same time, advanced technologies such as positron emission tomography (PET) and magnetic resonance imaging (MRI) are being integrated into the data collection process. These technologies pave the way for a more detailed assessment of patients’ cardiac status, thereby enhancing the accuracy of models and their ability to predict postoperative outcomes.

Integration of Risk Calculators into Clinical Practice

The routine use of risk calculators in clinical practice is now standard practice. Hospitals and specialized centers rely heavily on interactive online tools to quickly and accurately assess surgical risks. These tools help facilitate informed medical decisions while providing patients with more transparent and detailed information about the potential risks and benefits of surgical procedures.

Furthermore, electronic medical record (EMR) management systems have also evolved to integrate these calculators. This integration ensures seamless data flow, enabling continuous assessment and optimal monitoring throughout the course of care. It helps improve the quality and safety of interventions by reducing errors and optimizing available resources, particularly in critical care. Finally, continuing education is essential to ensure that healthcare professionals make optimal use of these tools. Conferences, workshops, and online training programs are regularly organized to keep medical teams up to date on the latest advances in this critical field. Conclusion: Risk calculators in cardiac surgery, such as the EuroSCORE, the STS score, and the Ambler score, play a vital role in estimating operative mortality and morbidity. Thanks to these tools, it is possible to effectively stratify patients to reduce the subjectivity of risk assessment and improve the overall quality of care provided. Each score has its strengths and weaknesses, and their selection always depends on the specific nature of the surgical procedure as well as the individual characteristics of each patient. However, these tools should not be used in isolation. It is essential to integrate them into daily clinical practice and complement them with expert clinical judgment. Constant technological advancements and regular revisions of these models ensure increasing accuracy in predicting postoperative outcomes. To maximize the positive impact of these calculators, their systematic use is essential. It is equally important to continue optimizing them through the analysis of data from clinical practice and advances in technological innovations. This is how we can make more informed medical decisions and significantly improve cardiac surgery outcomes for patients.

FAQ

What are the main risk calculators used in cardiac surgery, and what are their respective purposes?

The main risk calculators used in cardiac surgery are the Euroscore, the STS score, and the Ambler score.

• Euroscore: Developed by the European Association of Cardio-Thoracic Surgery, it estimates 30-day postoperative mortality for all types of cardiac surgery. Both additive and logistic versions are available.
• STS Score: Derived from the Society of Thoracic Surgeons database, it is based on a larger number of variables than the EuroSCORE. This score is used to estimate operative mortality and morbidity for different types of cardiac surgery.
• Ambler Score: Developed specifically for valvular heart disease, it is based on a database provided by the Society of Cardiothoracic Surgeons of Great Britain and Ireland.

How is the EuroSCORE calculated, and what is the difference between the additive and logistic versions?

The EuroSCORE assesses the risk of mortality following cardiac surgery using various variables. Here are the main differences between the two versions:

• EuroSCORE Add-on: This model assigns a simple sum of points (based on 17 risk factors) to assess risk. While convenient, it may underestimate the risk for high-risk patients.
• Logistic EuroSCORE: This model uses a calculation based on logistic regression to combine risk factors. This provides a more accurate prediction, particularly for high-risk patients.

The logistic model is more rigorous, but using it requires more advanced computational tools.

What are the main differences between the STS score and the EuroSCORE score in terms of the variables used and the types of cardiac surgery assessed?

The differences between these two scores lie primarily in the number of variables taken into account and the specific nature of the types of surgery assessed:

• STS Score: Developed by the Society of Thoracic Surgeons, it is based on more than 50 demographic and surgical variables. In addition, it provides specific models for various types of cardiac surgery, such as valve or coronary artery bypass surgery.
• EuroSCORE II: Developed by the European Association of Cardio-Thoracic Surgery, this score is based on 18 variables. Although it is more general and easier to calculate, it can be applied to all types of cardiac surgery, without making a precise distinction between different types of procedures.

Why was the Ambler score specifically developed for valve surgery, and how does it compare to other risk scores?

The Ambler score was designed specifically for valve surgery using a database compiled by the Society of Cardiothoracic Surgeons of Great Britain and Ireland. Its purpose is to estimate in-hospital mortality for these patients. Its distinctive features include:

• Greater focus on valvular heart disease, unlike the more general EuroSCORE.
• There is a risk of overestimation, particularly in high-risk patients, whereas the EuroSCORE II is more accurate and better calibrated in this regard.

Compared to the STS score, the Ambler score is simpler but uses fewer variables, making it less comprehensive for other types of cardiac surgery.

‍